...
首页> 外文期刊>International journal of medical and biological frontiers. >Arginine Conserves the Hemostasis Activation State of Plasma Even Against Freezing/Thawing
【24h】

Arginine Conserves the Hemostasis Activation State of Plasma Even Against Freezing/Thawing

机译:精氨酸可以保存血浆的止血激活状态,即使冻结/解冻

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical hemostasis activation can be very dangerous, e.g. in pathologic disseminated intravascular coagulation (PDIC). Long transport times of this unstable plasma into the hemostasis laboratory or freezing/thawing of the samples induces artefactual hemostasis changes. 308 unselected EDTA plasmas of patients were analyzed for plasmatic amidolytic thrombin activity. EDTA-plasmas of 94 patients were stabilized with 1.25 M plasma concentration arginine and analyzed for plasmatic amidolytic thrombin activity directly or after freezing at -24癈/thawing at room temperature (RT). EDTA-plasmas were supplemented with 0-1100 mM arginine, stored for 24h at RT, and analyzed for plasmatic thrombin activity.The normal donor range of amidolytic thrombin activity in plasma is 100 (+-) 20 % of normal, the overall patient range is 131 (+-) 40 % of normal (mean value (+-) 1 standard deviation); the thrombin activity in patient plasmas distributes normally according to Gauss. Analysis of arginine-stabilized EDTA-plasma prior to or after freezing/thawing correlate with r=0.980, however thrombin activity in unstabilized frozen EDTA-plasma correlates only with r=0.835 to that of stabilized plasma. Addition of EDTA-plasma to arginine correlates with addition of arginine to polystyrol wells that were pre-incubated for 2h with EDTA-plasma (r=0.965). Addition of > 50 mM arginine to plasma increases the stability of thrombin activity after 24h storage at RT in individual plasmas, with an increase of correlation from r=0.824 to r > 0.9.Arginine stabilization of EDTA-plasma enables the analysis of the true hemostasis activation state of a patient even in frozen plasma. This might be of great impact on both diagnosis and therapy of hemostasis disorders.
机译:临床止血激活可能非常危险,例如在病理传播血管内凝血(PDIC)中。这种不稳定的血浆的长时间运输时间到止血实验室或样品的冷冻/融化会诱导人肌肉止血。分析了308例未选择的患者EDTA等离子体的血浆酰化凝血酶活性。用1.25 m的血浆浓度精氨酸稳定了94例患者的EDTA - 质量,并直接或在室温下-24癈/融化后直接或冷冻后的等离质胺溶解凝血酶活性(RT)。补充EDTA-PLASMAS 0-1100 mM精氨酸,在RT处储存24小时,并分析了血浆凝血酶活性。等离子体中酰胺溶解凝血酶活性的正常供体范围为100(+ - )正常患者范围的20%,是整体患者范围为正常值的131(+ - )40%(平均值(+ - )1标准偏差);患者血浆中的凝血酶活性根据高斯正常分布。在冷冻/融化之前或之后,分析精氨酸稳定的EDTA-铂与r = 0.980相关,然而,未稳定的冷冻EDTA-Plasma中的凝血酶活性仅与r = 0.835与稳定等离子体相关。在精氨酸中添加EDTA-铂与将精氨酸添加到与EDTA-PLASMA 2H预孵育2H的聚酯井中相关(r = 0.965)。在RT在单个等离子体中储存24小时后,在血浆中添加> 50 mM的精氨酸增加了凝血酶活性的稳定性,其相关性从r = 0.824增加到r> 0.9。即使在冷冻血浆中,患者的激活状态也是如此。这可能对止血疾病的诊断和治疗都有很大的影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号